CXMT IPO: $85.5B valuation and the US blacklist gap

Key takeaways

• CXMT priced its STAR Market IPO at 8.66 yuan per share, implying a 579.2B yuan, or $85.5B, market value before over-allotment.
• The online retail tranche was 243.93x oversubscribed. After a clawback, final demand was about 212x. The 0.47% winning rate was the highest in STAR Market history, so demand was strong, not indiscriminate.
• The Pentagon lists CXMT as a Chinese military company. A US interagency committee approved it for the Commerce Department’s Entity List, but Commerce has not published the addition.
• A Trade.xyz pre-IPO perpetual on Hyperliquid marked near $7.37 on July 16, implying roughly $493B. It briefly traded at $8.64, and it is not equity.

CXMT headquarters campus in Hefei, China. Source: Gasgoo.

What happened in the CXMT IPO

The ChangXin Memory Technologies, or CXMT, IPO priced 6.69B shares at 8.66 yuan each. The base deal raises 57.9B yuan, or $8.55B. A fully exercised over-allotment would lift proceeds to about 66.6B yuan, or $9.8B.

CXMT is scheduled to list on Shanghai’s STAR Market on July 27 under ticker 688825. The base offering is Asia’s largest IPO of 2026 so far and the biggest A-share semiconductor listing on record, overtaking SMIC’s 2020 deal.

Retail investors submitted enough orders to cover the initial online tranche 243.93 times. After a clawback increased the shares available to retail buyers, the final 0.47% winning rate implied about 212x demand.

That sounds euphoric. In context, it was restrained.

The 0.47% winning rate was the highest ever recorded on the STAR Market, meaning applicants had a better chance of receiving shares than in other recent deals. The STAR50 index had also fallen nearly 20% from its July 1 peak as investors worried about valuations and liquidity.

CXMT cleared the market. It did not suspend price discipline.

Why the memory cycle made this possible

The deal arrived at a favorable point in the DRAM cycle.

AI data centers are consuming high-bandwidth memory and pulling wafer capacity away from mainstream DRAM. China’s National Development and Reform Commission said the contract price for mainstream DDR4 8Gb DRAM was about 83% higher in January 2026 than in September 2025.

The cycle turned CXMT’s scale-up into earnings. Revenue reached 61.8B yuan in 2025, and the company turned profitable. In Q1 2026, revenue reached 50.8B yuan, up 719% year over year. Attributable net profit was 24.76B yuan. First-half revenue is expected at 110B to 120B yuan, nearly twice full-year 2025 sales.

The IPO is not a cash-out. CXMT says the proceeds will fund production-line upgrades, capacity, and R&D. State pension funds, chip-equipment supplier AMEC, and investment arms linked to Alibaba, Tencent, and Xiaomi also joined strategic placements.

China is using one transaction to fund a manufacturer, secure a supply chain, and align customers with the cap table.

The real signal: Washington named CXMT but did not restrict it

Two US lists matter here, and they do different things.

The Pentagon’s Chinese Military Companies list names firms it considers linked to China’s military. CXMT is on it. The designation is not the same as the Commerce Department’s Entity List.

The Entity List is the sharper tool. US suppliers generally need a license to ship listed companies US-origin goods, software, or technology, and approval is likely to be denied. Reuters reported that an interagency committee approved CXMT for addition more than a year ago. Commerce has not published it.

That is not an administrative footnote. The Entity List has not received new additions since October 2025, the longest pause in more than a decade. CXMT is one of more than 100 companies reportedly waiting in the gap.

Washington has already said what it thinks CXMT is. It has not applied the export-control mechanism that would make that view expensive.

Capital notices the difference. At $85.5B, the IPO is pricing a company with geopolitical risk, but no published policy action. The chip war is not over. The market is pricing enforcement as negotiable.

China’s DRAM push is no longer a science project

CXMT remains behind Samsung, SK Hynix, and Micron in advanced memory, especially high-bandwidth memory. That distinction matters. The company is not yet competing for the most demanding AI accelerator sockets.

It is competing where volume lives.

CXMT held about 7.7% of the global DRAM market in 2025, according to its prospectus. Counterpoint estimated its share at 8% in Q1 2026. Its advantage is not frontier performance. It is state-linked financing, domestic demand, and a large market that wants a non-US supplier.

That is enough to change the industry. A company does not need to win HBM to pressure commodity DRAM pricing. It needs yield, scale, and buyers.

The IPO gives CXMT more of all three.

A CXMT-branded DRAM memory module. Source: Wccftech.

Second-order effects: today’s scarcity capital can fund tomorrow’s oversupply

Every memory supercycle eventually finances the capacity that ends it.

Former Samsung chip head Kye-hyun Kyung warned in May that Chinese expansion could help push global memory capacity toward 6M wafers per month in H2 2027 and pull prices lower. The timing is uncertain, and installed capacity is not the same as saleable output. The direction is harder to dismiss.

CXMT is raising up to $9.8B to expand. SK Hynix raised $26.5B in a Nasdaq ADR sale four days before CXMT priced its deal, and its US-listed shares jumped 14% on debut. Both transactions monetized the same thesis: AI has made memory strategically scarce.

They are monetizing it from opposite positions.

SK Hynix sells leadership in HBM. CXMT sells the possibility that China can scale mainstream DRAM fast enough to break the shortage.

The incumbents’ current earnings are funding the supply response. CXMT’s IPO is funding the challenger that could make that response more violent.

Hyperliquid is already pricing the debut

Shanghai investors have to wait until July 27. Onchain traders did not.

Trade.xyz launched a CXMT pre-IPO perpetual through Hyperliquid’s HIP-3 framework on July 14. The contract traded from around $6 to a high of $8.64 by July 16. Using roughly 66.88B post-offering shares, a mark price near $7.37 implied a market value of about $493B. The $8.64 high would imply close to $578B.

The number is useful. The instrument needs context.

The contract does not deliver CXMT shares, IPO allocation rights, dividends, or voting power. Its price reflects an offshore, crypto-native pool of traders, not the order book that will open in Shanghai.

That is exactly why it matters. The perp is not a valuation certificate. It is a live measure of how aggressively unrestricted global capital wants to trade the narrative.

The regulated market set the offer at an $85.5B valuation.

Onchain traders briefly priced almost $580B.

July 27 decides how much of that gap was information and how much was reflexivity.

What to watch before July 27

• The debut and oracle transition: Compare the first STAR Market print with the 8.66 yuan offer price and the much higher Hyperliquid level. A sharp gap during the contract’s transition to an external share-price reference could create abrupt PnL and liquidation risk.
• The Entity List: Watch whether Commerce publishes any additions before or after the listing. A policy action would change CXMT’s access to US-origin tools and technology.
• DRAM pricing: Follow contract and spot data from TrendForce and China’s NDRC. The first break in mainstream pricing would test the scarcity thesis behind the deal.
• Competitor read-through: Listen for Micron, Samsung, and SK Hynix commentary on mainstream DRAM orders, utilization, and capital spending.
• Apple supply talks: Reports say Apple is in talks with CXMT for devices sold in China. A confirmed agreement would validate CXMT with a global customer and raise the political cost of tighter controls.

The bottom line

CXMT’s IPO is not evidence that US-China technology competition is over. It is evidence that markets price implementation, not intent.

China now has a profitable DRAM producer with scale, state backing, and fresh capital.

The Pentagon has named it.

Commerce has not restricted it.

Hyperliquid is already trading the gap.

The Entity List action is pending. The price signal is live.

How to trade CXMT on Markets.xyz

CXMT is live on Markets.xyz as a pre-IPO perpetual, giving traders 24/7 exposure to its price around the Shanghai listing without owning the underlying shares.

1. Open the CXMT market and connect your wallet.
2. Deposit funds.
3. Choose Long if you expect the price to rise or Short if you expect it to fall.
4. Enter your position size, select your leverage, and review the funding rate and liquidation price before confirming.

Trade CXMT on Markets.xyz

Sources

Figures, contract prices, and policy status are current as of July 17, 2026.

1. Reuters. CXMT’s $8.6 billion Shanghai IPO draws less frenzied demand amid China tech selloff⁠, July 16, 2026.
2. Reuters. China memory chipmaker CXMT aims to raise $8.6 billion in Asia’s biggest IPO of 2026 so far⁠, July 14, 2026.
3. Reuters. Explainer: What is CXMT and how did it become China’s DRAM champion?⁠, July 15, 2026.
4. Reuters. US holds off blacklisting China’s DeepSeek, more than 100 firms deemed security risks⁠, June 17, 2026.
5. The Wall Street Journal. China’s CXMT eyes $85.5 billion market cap ahead of blockbuster IPO⁠, July 15, 2026.
6. Reuters. SK Hynix shares jump in marquee US debut as AI euphoria persists⁠, July 10, 2026.
7. Counterpoint Research. Global DRAM and HBM market share: quarterly⁠, 2026.
8. Flyking, citing NDRC monitoring data. China’s NDRC warns memory price surge is spreading across the electronics supply chain⁠, January 27, 2026.
9. Wccftech. Ex-Samsung chip boss says China’s DRAM expansion could crush the DDR5 price spike⁠, May 18, 2026.
10. Hyperliquid. Trade.xyz CXMT perpetual market⁠, accessed July 17, 2026.
11. Wu Blockchain. How is a pre-IPO company’s share price determined on Hyperliquid?⁠, July 16, 2026.
12. Reuters Breakingviews. Apple’s China plea signals low-tech chip upheaval⁠, July 15, 2026.

This article is for informational purposes only and does not constitute investment advice. Derivatives can involve leverage, liquidation, and total-loss risk.